Two chemical libraries (147 compounds in an oncology drugs set and 390 compounds in a natural product library) screened against two INSM1-promoter driven luciferase assay platforms constructed in BE2-M17 and IMR-32 NB cells were selected. The gene discussed is INSM1; the disease is neuroblastoma.